Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Bullboard - Stock Discussion Forum Abbvie CDR ABBV


Primary Symbol: T.ABBV

Healthcare Drug Manufacturers - Major
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis... see more

Bullboard (TSX:ABBV)

View:
User Avatar Image
(1)
•••
  • EvansWilsonX
Post by EvansWilsonon Aug 29, 2025 4:43am

AbbVie’s Payout Rhythm: What Recent Dates Reveal

If you're tracking ABBV dividend date, the latest quarterly payout of $1.64 per share was made on August 15, 2025, to shareholders who held the stock before the ex-dividend date of July 15, 20252. ...more  
32
Post by 10QKingon Feb 12, 2025 2:12pm

$XLO 52 Million in Cash and over 2 Billion ABBV

$XLO 52 Million in Cash and over 2 Billion in Milestone payments with $ABBV https://www.stocktitan.net/news/XLO/abb-vie-and-xilio-therapeutics-announce-collaboration-and-option-x3e2lxgw8uc1.html
56
User Avatar Image
(33)
•••
  • SmartBull65X
Post by SmartBull65on Dec 03, 2024 3:44pm

ABBV: Botox Boost, But Humira’s Decline Looms 🧬

ABBV is solid for now, especially with Botox driving growth in aesthetics. But Humira’s revenue is dropping fast due to biosimilars. Rinvoq and Skyrizi are helping, but they still have big shoes to ...more  
131
User Avatar Image
(11)
•••
  • WrywisdomX
Post by Wrywisdomon Aug 10, 2022 3:21pm

Incredible Value. ENTG at about 25% of One Years Revenue

.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:   ...more  
380
User Avatar Image
(3)
•••
  • zeropointenergyX
Post by zeropointenergyon Oct 06, 2021 7:20am

ONE DRUG PILL WIPES OUT COVID 19!

India's Ivermectin Blackout - Part V: The Secret Revealed ...   Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free ...more  
500
User Avatar Image
(33)
•••
  • plomar2011X
Post by plomar2011on Sep 01, 2021 1:58pm

what was the big drop ?? saw no news

what was the big drop ?? saw no news
394